FSHR and ovarian carcinoma: Fan et al. 37conjugated the polypeptide of the follicle-stimulating hormone (FSH) to a nanoparticle (FSHP-NP) to target FDH receptors (FSHR) in lymphatic metastases of ovarian cancer.